Haemodynamic stabilisation in sepsis;Hamodynamische stabilisierung in der sepsis

Anasthesiologie und Intensivmedizin

Volumn 41, Issue 7-8, 2000, Pages 601-613

  Meier Hellmann, A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Hemodynamics; Monitoring, physiologic; Septicemia; Vasoconstrictor agents

Indexed keywords

CATECHOLAMINE; DOBUTAMINE; DOPAMINE; DOPEXAMINE; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR;

ARTERY CATHETER; CARDIOPULMONARY HEMODYNAMICS; ECHOCARDIOGRAPHY; HEMODYNAMIC MONITORING; HUMAN; PULMONARY ARTERY; REVIEW; SEPSIS;

EID: 0033827467     PISSN: 01705334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis
2. Colloids versus crystalloids in fluid resuscitation: An analysis of randomized controlled trials
3. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock
4. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
5. Comparison of clinical information gained from routine blood-gas analysis and from gastric tonometry for intramural pH
6. Monitoring the hepatico-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance
7. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function
8. Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine
9. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators
10. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection
11. Norepinephrine therapy has no deleterious renal effects in human septic shock
12. A reappraisal of norepinephrine therapy in human septic shock
13. Gastric mucosal pH as a prognostic index of mortality in critically ill patients
14. Renal support in critically ill patients: Low-dose dopamine or low-dose dobutamine?
15. Tissue hypoxia: How to detect, how to correct, how to prevent. Societe de Reanimation de Langue Francaise. The American Thoracic Society. European Society of Intensive Care Medicine
16. Predictive value of the stomach wall pH for complications after cardiac operations: Comparison with other monitoring
17. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group
18. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation
19. Intensive care physicians insufficient knowledge of right-heart catheterization at the bedside: Time to act?
20. Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man
21. Comparison of gastric intramucosal pH with measures of oxygen transport and consumption in critically ill patients
22. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients
23. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients
24. Development and validation of a technique for continuous monitoring of gastric intramucosal pH
25. Prognostic value of gastric intramural pH in surgical intensive care patients
26. Comparison of dopamine to dobutamine and norepinephrine for oxygen delivery and uptake in septic shock
27. Elevation of systemic oxygen delivery in the treatment of critically ill patients
28. Eingeschrankte Herzfrequenzvariabilitat bei Patienten mit septischem und nichtseptischem Multiorgan-Dysfunktions-Syndrom
29. Low dose norepinephrine in patients with septic shock and oliguria: Effects on afterload, urine flow, and oxygen transport
30. Maximizing oxygen delivery in critically ill patients: A methodologic appraisal of the evidence
31. The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline
32. Hepatic venous hemoglobin oxygen saturation predicts liver dysfunction after hepatectomy
33. Enoximone in contrast to dobutamine improves hepatico-splanchnic function in fluid-optimized septic shock patients
34. Prognostic significance of indocyanine green clearance in critically ill surgical patients
35. Effect of a dopexamine-induced increase in cardiac index on splanchnic Hemodynamics in septic shpck
36. 2-Messung als gastrointestinales Monitoring
37. Gastric tonometry: Precision and reliability are improved by a phosphate buffered solution
38. 2 measurement in six standard blood gas analysers using a phosphate-buffered solution for gastric tonometry
39. A new method for continuous intramucosal PCO2 measurement in the gastrointestinal tract
40. Monitoring of the plasma disappearance rate (PDR) by indocyanine green (ICG) as a prognostic marker in critically ill patients?
41. Resuscitation of Patients in Septic Shock - 1st Asia-Pacific Consensus Conference in Critical Care Medicine
42. Monoethylglycinexylidide as an early predictor of posttraumatic multiple organ failure
43. Regional blood flow responses to vasodilators and inotropes in congestive heart failure
44. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study
45. Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock
46. Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines
47. Dopexamine hydrochloride in septic shock: Effects on oxygen delivery and oxygenation of gut, liver, and muscle
48. Gastric intramucosal pH. A better predictor of multiorgan dysfunction syndrome and death than oxygenderived variables in patients with sepsis
49. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis
50. Renal effects of norepinephrine used to treat septic shock patients
51. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure
52. Increasing splanchnic blood flow in the critically ill
53. Liver function and splanchnic ischemia in critically ill patients
54. The effects of low dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock
55. Dopexamine increases splanchnic blood flow but decreases gastric mucosal ph in severe septic patients treated with dobutamine
56. Epinephrine impairs splanchnic perfusion in septic shock
57. Epinephrine as an inotropic agent in septic shock: A doseprofile analysis
58. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients
59. Predictors of one-year pretransplant survival in patients with cirrhosis
60. Lignocaine metabolite formation as a measure of pre-transplant liver function
61. The cardiovascular pathophysiology of sepsis
62. Pulmonary Artery Catheter Consensus Conference: Consensus statement
63. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock
64. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock
65. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials
66. Effects of dopamine on total oxygen consumption and oxygen delivery in healthy men
67. Fluid resuscitation with colloid or crystalloid solutions in critically ill paitents: A systematic review of randomised trials
68. 2 in intestine during low flow
69. Tissue-arterial PCO2 difference is a better marker of ischemia than intramural pH (pHi) or arterial pH-pHi difference
70. Autonomic dysfunction in critically ill patients
71. Dopexamine maintains intestinal villus blood flow during endotoxemia in rats
72. Oxygen transport measurements to evaluate tissue perfusion and titrate therapy: Dobutamine and dopamine effects
73. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients
74. Round table conference on clinical trials for the treatment of sepsis
75. Gastric tonometry in patients with sepsis Effects of dobutamine infusions and packed red blood cell transfusions
76. Protecting the gut and the liver in the critically ill: Effects of dopexamine
77. Cardiovascular and renal haemodynamic effects of dopexamine Comparison with dopamine
78. Saline pCO2 is an important source of error in the assessment of gastric intramucosal pH
79. Abnormalities of gastric mucosal oxygenation in septic shock Partial responsiveness to dopexamine
80. Goal-directed therapy with dopexamine, dobutamine, and volume expansion: Effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis
81. Biological basis for PCO2 as a detector of ischemia
82. Elevation of cardiac output and oxygen delivery improves outcome in septic shock
83. Early hemodynamic correlates of survival in patients with septic shock
84. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green
85. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery
86. Anterior pituitary function during critical illness and dopamine treatment
87. Crystalloid versus colloid fluid resuscitation. A meta-analysis of mortality
88. Dopamine compared with dobutamine in experimental septic shock: Relevance to fluid administration
89. HZV-Bestimmung mittels transpulmonaler Thermodilution. Eine Alternative zum Pulmonaliskatheter?